A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin as an Antifungal Prophylaxis in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplant
Latest Information Update: 26 Nov 2015
At a glance
- Drugs Micafungin (Primary)
- Indications Candidiasis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
Most Recent Events
- 26 Nov 2015 New trial record